Roivant Sciences Ltd. (ROIV) — 13F Filings Explorer (Q2 2026)

ROIV ranks #1178 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ROIV is a top-conviction position for QVT Financial LP — at 49.4% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ROIV belongs to FMR LLC, but the position matters far more to QVT Financial LP, who has 49.4% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

State of Alaska, Department of Revenue has added to its ROIV position for two straight quarters, increasing it by $969.0K to reach $2.2M today.

ROIV is down 3.6% today, but institutions show net buying of $2.5B this quarter — a divergence between today's price move and the underlying institutional flow.

ROIV reported a net loss of $266.3M over the trailing twelve months.

• Not yet profitable — net loss of $266.3M over the trailing twelve months
• Revenue declined 67.6% year over year
• Net income improved year over year, from -$490.6M to -$266.3M
• Operating cash flow was negative, using $750.3M in cash
• Current ratio of 18.37x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.09x equity — within a conventional range